top of page
The Professional Network for Healthcare Experts
Mankind Pharma agrees €48 million acquisition of 70% stake in Armed Cell Therapeutics to enter CAR-T oncology
Mankind Pharma has agreed to acquire a 70% stake in Belgium's Armed Cell Therapeutics for €48 million, marking its entry into next-generation CAR-T oncology therapies.
nuaxia
Oct 162 min read
Galderma agrees $1.5 billion acquisition of ZO Skin Health to expand dermatological skincare portfolio
Galderma has agreed to acquire ZO Skin Health for an enterprise value of $1.5 billion, expanding its physician-dispensed dermatological skincare portfolio.
nuaxia
Oct 152 min read
GE HealthCare agrees $945m acquisition of SOFIE Biosciences to expand US radiopharma network
GE HealthCare has agreed to acquire SOFIE Biosciences for $945 million, expanding its US PET radiopharmaceutical manufacturing and distribution network.
nuaxia
Oct 62 min read
Shionogi agrees $2bn acquisition of IntraBio to expand rare disease portfolio
Shionogi has agreed to acquire IntraBio for $2 billion, adding the rare neurological disease therapy AQNEURSA and its global commercial rights to the Japanese group's portfolio.
nuaxia
Oct 52 min read
SpyGlass Pharma acquires Advanced Vision Science for $13m to secure intraocular lens manufacturing
SpyGlass Pharma has acquired Advanced Vision Science for approximately $13 million, bringing manufacturing of a key intraocular lens used in its drug-delivery platform in-house.
nuaxia
Oct 21 min read
Novotech agrees acquisition of Agilex Biolabs to expand bioanalytical capabilities in Australia
Novotech has agreed to acquire Agilex Biolabs, adding specialist bioanalytical laboratory capabilities to its Australian clinical-development platform.
nuaxia
Oct 21 min read
Arcturus Therapeutics agrees acquisition of AI drug-discovery company myNEO
Arcturus Therapeutics has agreed to acquire Belgian AI drug-discovery company myNEO, expanding its computational capabilities for mRNA medicine design and target identification.
nuaxia
Sep 252 min read
AVS Bio acquires Biorbyt to expand global biomaterials platform
AVS Bio has acquired Biorbyt, expanding its global life-sciences platform with a catalogue of more than one million antibodies, proteins and other research reagents.
nuaxia
Sep 242 min read
Lexeo agrees acquisition of Mantle Therapeutics to expand Friedreich ataxia pipeline
Lexeo Therapeutics has agreed to acquire Mantle Therapeutics for up to $21.3 million, adding four Friedreich ataxia development programmes to its pipeline.
nuaxia
Sep 232 min read
Grünenthal agrees acquisition of Bayer cancer drug Stivarga for up to €375m
Grünenthal has agreed to acquire Bayer's established oncology medicine Stivarga in a transaction worth up to €375 million.
nuaxia
Sep 222 min read
Telix and ITM agree $1.65bn radiopharmaceutical merger
Telix Pharmaceuticals has agreed to acquire ITM in a major radiopharmaceutical transaction valued at $1.65 billion upfront, with up to a further $700 million linked to regulatory and commercial milestones.
nuaxia
Sep 212 min read
Sudarshan Pharma approves acquisition of 9.5% stake in MedTherapy Biotechnology
Sudarshan Pharma has approved the acquisition of a 9.5% stake in US-based MedTherapy Biotechnology, expanding its exposure to oncology cell and gene therapy.
nuaxia
Sep 82 min read
Cureety acquires Reimagine Care to expand precision oncology platform
The acquisition combines Cureety's therapy-specific oncology monitoring platform with Reimagine Care's AI-enabled virtual cancer-care capabilities.
nuaxia
Sep 42 min read
bottom of page